Literature DB >> 17466963

Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract.

Zehra Hashim1, Shamshad Zarina.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate antioxidant effect of paraoxonase 1 activity and malondialdehyde (MDA) levels as a marker of oxidative stress in patients suffering from cataract due to diabetes and aging. DESIGN AND METHODS: One hundred cataract patients (senile and diabetic) and age- and sex-matched controls were studied. Paraoxonase 1 and arylesterase activities in plasma samples were measured using paraoxon and phenylacetate as substrates, respectively. The magnitude of lipid peroxidation was established by measuring plasma MDA and oxidized low-density lipoprotein (ox LDL) levels. One-way ANOVA was employed for analysis of results.
RESULTS: We observed significantly lower plasma paraoxonase and arylesterase activities in senile and diabetic cataractous patients as compared to respective controls (p<0.001). Plasma MDA and ox LDL levels were found to be higher in patients suffering from cataract (p<0.001).
CONCLUSIONS: The results of present study suggest that the observed decrease in PON1 activity may be due to increase in oxidative stress. It can be concluded that lower paraoxonase activity could contribute to the higher risk of cataract formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17466963     DOI: 10.1016/j.clinbiochem.2007.03.015

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  9 in total

1.  Impact of Vitamin E Supplementation on Blood Pressure and Hs-CRP in Type 2 Diabetic Patients | doi: 10.5681/hpp.2012.009.

Authors:  Maryam Rafraf; Behnaz Bazyun; Mohammad Ali Sarabchian; Abdolrasoul Safaeiyan; Seyed Jamal Ghaemmaghami Hezaveh
Journal:  Health Promot Perspect       Date:  2012-07-01

2.  Changes of total antioxidant capacity and total oxidant status of aqueous humor in diabetes patients and correlations with diabetic retinopathy.

Authors:  Emrullah Beyazyıldız; Ali Bülent Cankaya; Esra Ergan; Mustafa Alparslan Anayol; Yasemin Ozdamar; Sevilay Sezer; Mehmet Hakan Tırhış; Pelin Yılmazbaş; Faruk Oztürk
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

3.  Docking and molecular dynamics simulation studies on glycation-induced conformational changes of human paraoxonase 1.

Authors:  Ammara Saleem; S Sikander Azam; Shamshad Zarina
Journal:  Eur Biophys J       Date:  2011-12-23       Impact factor: 1.733

4.  Clinical Association of Biochemical Variations Among Multilocus Genotypes of Antioxidant Enzymes with Susceptibility of Cataract in Hyperglycemia.

Authors:  Sanober Kafeel; Asher Fawwad; Abdul Basit; Syeda Nuzhat Nawab
Journal:  Appl Biochem Biotechnol       Date:  2022-05-12       Impact factor: 3.094

5.  Contribution of cholesterol and oxysterols in the physiopathology of cataract: implication for the development of pharmacological treatments.

Authors:  Anne Vejux; Mohammad Samadi; Gérard Lizard
Journal:  J Ophthalmol       Date:  2011-04-04       Impact factor: 1.909

Review 6.  The Contribution of Fluoride to the Pathogenesis of Eye Diseases: Molecular Mechanisms and Implications for Public Health.

Authors:  Declan Timothy Waugh
Journal:  Int J Environ Res Public Health       Date:  2019-03-08       Impact factor: 3.390

7.  Age-dependent paraoxonase 1 (PON1) activity and LDL oxidation in Wistar rats during their entire lifespan.

Authors:  Dileep Kumar; Syed Ibrahim Rizvi
Journal:  ScientificWorldJournal       Date:  2014-05-22

8.  Ocular distribution of antioxidant enzyme paraoxonase & its alteration in cataractous lens & diabetic retina.

Authors:  Subramaniam Rajesh Bharathidevi; Kannadasan Anand Babu; Nishit Jain; Sivashanmugam Muthukumaran; Vetrivel Umashankar; J Biswas; Narayanasamy Angayarkanni
Journal:  Indian J Med Res       Date:  2017-04       Impact factor: 2.375

9.  Paraoxonase 1 activities and its gene promoter single nucleotide polymorphisms (-108, -126, and -162) in diabetes mellitus.

Authors:  Asefesadat Emami; Mohamadhasan Tajadini; Mehrdad Zeinalian; Mahtab Keshvari; Sedigheh Asgary
Journal:  Interv Med Appl Sci       Date:  2018-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.